---
title: "Texas Capital Bancshrs Pref Share TCBIO 5.75 Perp 06/15/26 B | 10-Q: FY2025 Q3 Revenue: USD 529.2 M"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/262435343.md"
published_at: "2025-10-23T12:22:00.000Z"
---

# Texas Capital Bancshrs Pref Share TCBIO 5.75 Perp 06/15/26 B | 10-Q: FY2025 Q3 Revenue: USD 529.2 M

Revenue: As of FY2025 Q3, the actual value is USD 529.2 M.

EPS: As of FY2025 Q3, the actual value is USD 2.18.

EBIT: As of FY2025 Q3, the actual value is USD -133.99 M.

### Segment Revenue

-   **Commercial Loans**: $11,999,025 as of September 30, 2025, up from $11,145,591 as of December 31, 2024.
-   **Mortgage Finance Loans**: $6,057,804 as of September 30, 2025, up from $5,215,574 as of December 31, 2024.
-   **Commercial Real Estate Loans**: $5,696,720 as of September 30, 2025, up from $5,616,282 as of December 31, 2024.
-   **Consumer Loans**: $540,126 as of September 30, 2025, down from $565,376 as of December 31, 2024.

### Operational Metrics

-   **Net Interest Income**: $271,771 for the three months ended September 30, 2025, compared to $240,102 for the same period in 2024.
-   **Provision for Credit Losses**: $12,000 for the three months ended September 30, 2025, compared to $10,000 for the same period in 2024.
-   **Non-interest Income**: $68,583 for the three months ended September 30, 2025, compared to -$114,771 for the same period in 2024.
-   **Non-interest Expense**: $190,575 for the three months ended September 30, 2025, compared to $195,324 for the same period in 2024.

### Cash Flow

-   **Net Cash Provided by Operating Activities**: $229,660 for the nine months ended September 30, 2025.
-   **Net Cash Used in Investing Activities**: -$1,890,276 for the nine months ended September 30, 2025.
-   **Net Cash Provided by Financing Activities**: $1,536,633 for the nine months ended September 30, 2025.

### Unique Metrics

-   **Net Charge-offs**: $36,502 for the nine months ended September 30, 2025, compared to $28,802 for the same period in 2024.
-   **Allowance for Credit Losses on Loans**: $274,026 as of September 30, 2025, compared to $271,709 as of December 31, 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: The company aims to maintain a strong liquidity position and manage interest rate risk effectively. It plans to continue focusing on customer deposits as a primary funding source, supplemented by short-term borrowings and long-term debt.
-   **Non-Core Business**: The company has authorized a new share repurchase program of up to $200 million, set to expire on January 31, 2026, to manage its capital structure effectively.

### Related Stocks

- [TCBIO.US - Texas Capital Bancshrs Pref Share TCBIO 5.75 Perp 06/15/26 B](https://longbridge.com/en/quote/TCBIO.US.md)

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.